Beta Bionics (BBNX) Competitors $24.87 -0.13 (-0.52%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BBNX vs. NVST, LIVN, WRBY, INSP, LQDA, LMAT, PRCT, AORT, EYE, and ENOVShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), LeMaitre Vascular (LMAT), PROCEPT BioRobotics (PRCT), Artivion (AORT), National Vision (EYE), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Its Competitors Envista LivaNova Warby Parker Inspire Medical Systems Liquidia Technologies LeMaitre Vascular PROCEPT BioRobotics Artivion National Vision Enovis Beta Bionics (NASDAQ:BBNX) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership. Does the media refer more to BBNX or NVST? In the previous week, Beta Bionics had 8 more articles in the media than Envista. MarketBeat recorded 20 mentions for Beta Bionics and 12 mentions for Envista. Envista's average media sentiment score of 1.32 beat Beta Bionics' score of 0.58 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Envista 9 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, BBNX or NVST? Beta Bionics has higher earnings, but lower revenue than Envista. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$78.02M13.86-$54.76MN/AN/AEnvista$2.55B1.35-$1.12B$0.3264.86 Do analysts prefer BBNX or NVST? Beta Bionics currently has a consensus price target of $22.56, suggesting a potential downside of 9.31%. Envista has a consensus price target of $20.92, suggesting a potential upside of 0.81%. Given Envista's higher probable upside, analysts clearly believe Envista is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75Envista 1 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.33 Is BBNX or NVST more profitable? Envista has a net margin of 2.11% compared to Beta Bionics' net margin of 0.00%. Envista's return on equity of 4.84% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Envista 2.11%4.84%2.68% SummaryEnvista beats Beta Bionics on 6 of the 11 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.08B$6.75B$5.78B$10.04BDividend YieldN/A1.14%5.27%4.52%P/E RatioN/A25.8875.5726.08Price / Sales13.86144.80516.51171.66Price / CashN/A22.1637.2059.76Price / Book-4.354.9311.536.20Net Income-$54.76M$178.27M$3.29B$270.65M7 Day Performance26.37%-0.09%0.44%2.77%1 Month Performance68.72%3.10%10.84%8.83%1 Year PerformanceN/A8.02%61.62%27.49% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta BionicsN/A$24.87-0.5%$22.56-9.3%N/A$1.08B$78.02M0.00294News CoverageInsider TradeNVSTEnvista3.6006 of 5 stars$20.77+2.3%$20.92+0.8%+22.7%$3.37B$2.51B64.8912,300News CoveragePositive NewsLIVNLivaNova2.2937 of 5 stars$58.15+2.8%$59.71+2.7%+24.7%$3.09B$1.25B-14.952,900News CoveragePositive NewsWRBYWarby Parker1.5431 of 5 stars$25.41+0.6%$24.06-5.3%+93.4%$2.66B$771.32M-362.883,780Positive NewsAnalyst DowngradeINSPInspire Medical Systems4.9806 of 5 stars$86.59+1.2%$164.50+90.0%-61.6%$2.53B$802.80M50.051,246Positive NewsLQDALiquidia Technologies3.495 of 5 stars$28.84-1.3%$32.11+11.3%+201.8%$2.52B$14M-16.9650LMATLeMaitre Vascular3.6067 of 5 stars$97.07+2.7%$97.60+0.5%+10.5%$2.14B$219.86M47.12490Positive NewsPRCTPROCEPT BioRobotics3.3779 of 5 stars$38.34+1.3%$73.22+91.0%-48.5%$2.11B$224.50M-24.74430Positive NewsAORTArtivion3.2313 of 5 stars$44.00+1.6%$40.63-7.6%+74.6%$2.04B$388.54M-104.751,600EYENational Vision3.1305 of 5 stars$23.11+1.4%$24.73+7.0%+135.0%$1.80B$1.82B-128.3913,411Positive NewsENOVEnovis4.1795 of 5 stars$31.53+2.9%$51.00+61.7%-27.5%$1.75B$2.11B-2.217,367Positive News Related Companies and Tools Related Companies Envista Competitors LivaNova Competitors Warby Parker Competitors Inspire Medical Systems Competitors Liquidia Technologies Competitors LeMaitre Vascular Competitors PROCEPT BioRobotics Competitors Artivion Competitors National Vision Competitors Enovis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBNX Stock Alerts